Top Medical Journal Retracts E-Cigarette Smoking Cessation Effectiveness Paper

Industry Insight by 2FIRSTS
Apr.15.2024
Top Medical Journal Retracts E-Cigarette Smoking Cessation Effectiveness Paper
JAMA retracts e-cigarette quitting study for major coding errors and doubts on accuracy, causing widespread concern and controversy.

Recently, the Journal of the American Medical Association (JAMA) retracted an article published two months ago about vaping e-cigarettes due to researchers notifying the editors of "significant coding errors" and other issues in the study.

Top Medical Journal Retracts E-Cigarette Smoking Cessation Effectiveness Paper
Withdrawal page | Image source: American Medical Association Journal

 

This paper titled "Effectiveness of e-cigarettes compared with varenicline and nicotine gum for smoking cessation: a randomized clinical trial" was originally published in the January 29th issue of JAMA Internal Medicine, led by Dr. Liu Zhaobo from the Smoking Control and Respiratory Disease Prevention Department at Beijing Friendship Hospital. The researchers in this study found that in terms of helping people quit smoking, using e-cigarettes is not inferior to prescription medications and is more effective than nicotine gum. The paper has garnered widespread attention in the medical community, non-professional media, and social media.

 

Top Medical Journal Retracts E-Cigarette Smoking Cessation Effectiveness Paper
Withdrawal notice | Image source: Journal of the American Medical Association

 

However, the article was later retracted.

 

The retraction notice for this paper was issued on March 29th as follows:

 

We have identified significant coding errors that are difficult to correct. We also found discrepancies in the calculations, which have raised doubts about the accuracy and reliability of the reported results. Therefore, we believe it is necessary to retract this article in order to maintain the integrity of scientific research and uphold the trust of our readers and the medical community. All co-authors have agreed to the retraction. We sincerely apologize for any inconvenience or confusion this may have caused.

 

According to the academic media Research Gate, Liu Zhao later responded to media inquiries via email, stating that the article was voluntarily retracted by the research team. He provided the following explanation in response:

 

As we explained to the editors of the Journal of the American Medical Association, following the publication of this paper, we plan to conduct a secondary analysis. In this process, we discovered that 109 participants who should have been in the NRT group were incorrectly placed in the EC group, and another 109 participants who should have been in the EC group were incorrectly placed in the NRT group. We immediately conducted an analysis and found that the main results had changed, therefore, we promptly wrote a letter to the editor explaining this issue and requesting the retraction of the paper.

 

Furthermore, according to publicly available information, no other articles have been affected by these issues. According to Clarivate's Web of Science, the research findings in question have been cited once.

 

Dr. Liu Chaobo, the first author of the paper by the group called 2FIRSTS, was contacted for details regarding the withdrawal notice. Dr. Liu stated that the withdrawal notice was clearly explained and no further information could be disclosed. Additionally, a call was made to the Tobacco Control and Cessation Center at the China-Japan Friendship Hospital to inquire about the details, but the staff member who answered the call claimed to be unaware of the situation.

 

2FIRSTS will continue to follow the latest developments on the research paper and its retraction.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.

Ukraine Dismisses E-Cigarette Retail Violation Case Citing Procedural Flaws and Insufficient Evidence
Ukraine Dismisses E-Cigarette Retail Violation Case Citing Procedural Flaws and Insufficient Evidence
The Rivne Court of Appeal in Ukraine has overturned an administrative penalty in a case involving the sale of e-cigarette e-liquids, citing insufficient evidence and procedural irregularities. The court ruled that the original decision failed to prove the defendant’s wrongdoing beyond reasonable doubt, leading to the cancellation of the fine.
May.13 by 2FIRSTS.ai
PMI Brazil CEO Urges Policy Rethink, Backs Smoke-Free Alternatives Like IQOS and Zyn
PMI Brazil CEO Urges Policy Rethink, Backs Smoke-Free Alternatives Like IQOS and Zyn
Branko Svarcic, CEO of Philip Morris Brazil, says the country should rethink its public health approach, especially on e-cigarettes and heated tobacco. While Brazil has banned e-cigarettes since 2009, products like IQOS and Zyn are seen as harm-reduction tools in many countries. He urged the government to learn from global examples and update its policies.
May.26 by 2FIRSTS.ai
BAT Rolls Out Updated glo™ and neo™ Series in Japan Starting May
BAT Rolls Out Updated glo™ and neo™ Series in Japan Starting May
British American Tobacco Japan will launch a limited-edition version of its heated tobacco device, the glo Hyper Pro “Aurora,” starting May 26. The company also revamped its neo™ line on April 15, introducing updated names, flavors, and packaging. A new tobacco stick variant, “Neo Brilliant Red Fruits for Hyper,” was added to cater to evolving consumer preferences in Japan.
May.12 by 2FIRSTS.ai
Five Key Takeaways from the E-Cigarette Regulatory Press Conference: Stricter Oversight, Production Control, and Crackdown on Grey Market — In-Depth Analysis by 2Firsts’ Alan Zhao on Policy Logic and Industry Impact
Five Key Takeaways from the E-Cigarette Regulatory Press Conference: Stricter Oversight, Production Control, and Crackdown on Grey Market — In-Depth Analysis by 2Firsts’ Alan Zhao on Policy Logic and Industry Impact
Ahead of World No Tobacco Day, China’s tobacco regulator signaled a push for stricter e-cigarette oversight at a press conference. 2Firsts CEO Alan Zhao noted that regulation is entering a deeper phase, with new focus on export re-entry, international pressure, and the inclusion of herbal vapor products. Authorities also vowed to crack down on illegal operations and unapproved projects.
May.30 by 2FIRSTS.ai
UK and Ireland Health Authorities Recall Three E-Cigarette Products Over Excess Nicotine and Mislabeling as “Nicotine-Free”
UK and Ireland Health Authorities Recall Three E-Cigarette Products Over Excess Nicotine and Mislabeling as “Nicotine-Free”
Ireland’s Health Service Executive (HSE) has warned that three e-cigarette products falsely labeled as “nicotine-free” actually contain high nicotine levels and illegal e-liquid volumes. The HSE reported the issue to the EU’s RAPEX system and urged consumers to stop using the products and retailers to recall them.
May.13 by 2FIRSTS.ai
Malaysia’s Negeri Sembilan May Ban E-Cigarettes Pending State Council Review
Malaysia’s Negeri Sembilan May Ban E-Cigarettes Pending State Council Review
Negeri Sembilan may impose a state-wide e-cigarette ban, with Chief Minister Aminuddin backing the Malaysian Medical Association’s call and referring the proposal to the state executive council.
May.22 by 2FIRSTS.ai